

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | COPI coating of Golgi vesicle (GO:0048205) | 6.67689494 |
| 2 | Golgi transport vesicle coating (GO:0048200) | 6.67689494 |
| 3 | cell adhesion mediated by integrin (GO:0033627) | 4.61357771 |
| 4 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 4.51240483 |
| 5 | COPII vesicle coating (GO:0048208) | 4.48883841 |
| 6 | protein retention in ER lumen (GO:0006621) | 3.94998488 |
| 7 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 3.83084386 |
| 8 | skin morphogenesis (GO:0043589) | 3.81963748 |
| 9 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 3.78979192 |
| 10 | positive regulation of nuclease activity (GO:0032075) | 3.73103475 |
| 11 | protein localization to endosome (GO:0036010) | 3.61564295 |
| 12 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.57352063 |
| 13 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.57352063 |
| 14 | ER overload response (GO:0006983) | 3.53266626 |
| 15 | negative regulation of protein localization to plasma membrane (GO:1903077) | 3.50749378 |
| 16 | regulation of nuclease activity (GO:0032069) | 3.50733254 |
| 17 | peptidyl-proline hydroxylation (GO:0019511) | 3.44906555 |
| 18 | desmosome organization (GO:0002934) | 3.38895418 |
| 19 | endoplasmic reticulum unfolded protein response (GO:0030968) | 3.38373812 |
| 20 | signal peptide processing (GO:0006465) | 3.37635184 |
| 21 | hemidesmosome assembly (GO:0031581) | 3.30900190 |
| 22 | cellular response to unfolded protein (GO:0034620) | 3.28332951 |
| 23 | nucleotide-sugar biosynthetic process (GO:0009226) | 3.25748407 |
| 24 | protein hydroxylation (GO:0018126) | 3.25501851 |
| 25 | protein maturation by protein folding (GO:0022417) | 3.20088697 |
| 26 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.17424625 |
| 27 | cellular response to topologically incorrect protein (GO:0035967) | 3.12949604 |
| 28 | ER-nucleus signaling pathway (GO:0006984) | 3.12353419 |
| 29 | membrane budding (GO:0006900) | 3.08673014 |
| 30 | vesicle coating (GO:0006901) | 3.00743206 |
| 31 | folic acid-containing compound biosynthetic process (GO:0009396) | 2.99485264 |
| 32 | regulation of transforming growth factor beta2 production (GO:0032909) | 2.96882862 |
| 33 | negative regulation of establishment of protein localization to plasma membrane (GO:0090005) | 2.95702416 |
| 34 | membrane raft organization (GO:0031579) | 2.93654875 |
| 35 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.88748305 |
| 36 | pyrimidine nucleoside salvage (GO:0043097) | 2.87473782 |
| 37 | pyrimidine-containing compound salvage (GO:0008655) | 2.87473782 |
| 38 | valine metabolic process (GO:0006573) | 2.86434211 |
| 39 | cellular copper ion homeostasis (GO:0006878) | 2.85165753 |
| 40 | 4-hydroxyproline metabolic process (GO:0019471) | 2.80113191 |
| 41 | pyrimidine ribonucleoside monophosphate biosynthetic process (GO:0009174) | 2.79920779 |
| 42 | UMP metabolic process (GO:0046049) | 2.79920779 |
| 43 | pyrimidine ribonucleoside monophosphate metabolic process (GO:0009173) | 2.79920779 |
| 44 | UMP biosynthetic process (GO:0006222) | 2.79920779 |
| 45 | peptide catabolic process (GO:0043171) | 2.79703518 |
| 46 | monoubiquitinated protein deubiquitination (GO:0035520) | 2.78980689 |
| 47 | endodermal cell differentiation (GO:0035987) | 2.78694505 |
| 48 | ER to Golgi vesicle-mediated transport (GO:0006888) | 2.78651966 |
| 49 | collagen fibril organization (GO:0030199) | 2.78368479 |
| 50 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 2.78245676 |
| 51 | hyaluronan catabolic process (GO:0030214) | 2.78186657 |
| 52 | hormone catabolic process (GO:0042447) | 2.77378342 |
| 53 | negative regulation of epidermal growth factor-activated receptor activity (GO:0007175) | 2.74289342 |
| 54 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 2.73487828 |
| 55 | type B pancreatic cell proliferation (GO:0044342) | 2.72353654 |
| 56 | nucleoside salvage (GO:0043174) | 2.71850463 |
| 57 | very-low-density lipoprotein particle assembly (GO:0034379) | 2.71029493 |
| 58 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.70118279 |
| 59 | basement membrane organization (GO:0071711) | 2.70075225 |
| 60 | keratan sulfate catabolic process (GO:0042340) | 2.68594413 |
| 61 | nucleotide salvage (GO:0043173) | 2.68574576 |
| 62 | positive regulation of histone deacetylation (GO:0031065) | 2.68164511 |
| 63 | regulation of RIG-I signaling pathway (GO:0039535) | 2.66726564 |
| 64 | viral entry into host cell (GO:0046718) | 2.66077256 |
| 65 | positive regulation of endothelial cell apoptotic process (GO:2000353) | 2.65447127 |
| 66 | regulation of transforming growth factor beta1 production (GO:0032908) | 2.65401127 |
| 67 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 2.63841731 |
| 68 | positive regulation of p38MAPK cascade (GO:1900745) | 2.63611885 |
| 69 | iron ion import (GO:0097286) | 2.63161446 |
| 70 | response to endoplasmic reticulum stress (GO:0034976) | 2.60975974 |
| 71 | growth hormone receptor signaling pathway (GO:0060396) | 2.60398077 |
| 72 | epithelial cell-cell adhesion (GO:0090136) | 2.60082932 |
| 73 | cell-substrate junction assembly (GO:0007044) | 2.59241920 |
| 74 | wound healing, spreading of epidermal cells (GO:0035313) | 2.56775276 |
| 75 | response to unfolded protein (GO:0006986) | 2.56493073 |
| 76 | hypotonic response (GO:0006971) | 2.56337724 |
| 77 | embryonic process involved in female pregnancy (GO:0060136) | 2.56167672 |
| 78 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.54579942 |
| 79 | regulation of low-density lipoprotein particle receptor biosynthetic process (GO:0045714) | 2.54165122 |
| 80 | L-serine transport (GO:0015825) | 2.53978164 |
| 81 | barbed-end actin filament capping (GO:0051016) | 2.53882733 |
| 82 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress (GO:0043 | 2.52738237 |
| 83 | endocrine pancreas development (GO:0031018) | 2.51365828 |
| 84 | regulation of type B pancreatic cell apoptotic process (GO:2000674) | 2.50992766 |
| 85 | regulation of metalloenzyme activity (GO:0048552) | 2.49121546 |
| 86 | apoptotic cell clearance (GO:0043277) | 2.49010253 |
| 87 | type B pancreatic cell development (GO:0003323) | 2.48655504 |
| 88 | protein-lipid complex assembly (GO:0065005) | 2.47783301 |
| 89 | response to topologically incorrect protein (GO:0035966) | 2.47296451 |
| 90 | branching involved in mammary gland duct morphogenesis (GO:0060444) | 2.46950062 |
| 91 | regulation of protein localization to plasma membrane (GO:1903076) | 2.46676315 |
| 92 | negative regulation of anoikis (GO:2000811) | 2.46536024 |
| 93 | chondrocyte development (GO:0002063) | 2.45508131 |
| 94 | localization within membrane (GO:0051668) | 2.45225560 |
| 95 | nuclear pore complex assembly (GO:0051292) | 2.45152728 |
| 96 | membrane protein ectodomain proteolysis (GO:0006509) | 2.44832128 |
| 97 | synaptonemal complex assembly (GO:0007130) | 2.44047724 |
| 98 | tricarboxylic acid metabolic process (GO:0072350) | 2.43951597 |
| 99 | mammary gland epithelial cell proliferation (GO:0033598) | 2.43564131 |
| 100 | regulation of RNA export from nucleus (GO:0046831) | 2.43014223 |
| 101 | regulation of cardioblast differentiation (GO:0051890) | 2.42845330 |
| 102 | ER-associated ubiquitin-dependent protein catabolic process (GO:0030433) | 2.42833038 |
| 103 | protein N-linked glycosylation via asparagine (GO:0018279) | 2.41393259 |
| 104 | negative regulation of fatty acid transport (GO:2000192) | 2.41189387 |
| 105 | negative regulation of retinoic acid receptor signaling pathway (GO:0048387) | 2.39486439 |
| 106 | histone H2A monoubiquitination (GO:0035518) | 2.39187232 |
| 107 | peptidyl-asparagine modification (GO:0018196) | 2.38591292 |
| 108 | piRNA metabolic process (GO:0034587) | 2.38522678 |
| 109 | nucleotide-sugar metabolic process (GO:0009225) | 2.38466309 |
| 110 | positive regulation of extracellular matrix organization (GO:1903055) | 2.37494193 |
| 111 | positive regulation of hormone biosynthetic process (GO:0046886) | 2.37152184 |
| 112 | protein N-linked glycosylation (GO:0006487) | 2.36845608 |
| 113 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.36246946 |
| 114 | L-phenylalanine catabolic process (GO:0006559) | 2.36246946 |
| 115 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.34656873 |
| 116 | pinocytosis (GO:0006907) | 2.34593775 |
| 117 | histone H3-K9 demethylation (GO:0033169) | 2.34473609 |
| 118 | plasma lipoprotein particle assembly (GO:0034377) | 2.33793178 |
| 119 | protein carboxylation (GO:0018214) | 2.32894101 |
| 120 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.32894101 |
| 121 | regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315) | 2.32170830 |
| 122 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 2.31808989 |
| 123 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 2.30810812 |
| 124 | L-phenylalanine metabolic process (GO:0006558) | 2.30810812 |
| 125 | pyrimidine nucleoside monophosphate biosynthetic process (GO:0009130) | 2.30729153 |
| 126 | paraxial mesoderm development (GO:0048339) | 2.30321215 |
| 127 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.30090070 |
| 128 | chaperone mediated protein folding requiring cofactor (GO:0051085) | 2.29463937 |
| 129 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.29184836 |
| 130 | cellular zinc ion homeostasis (GO:0006882) | 2.27324079 |
| 131 | embryo implantation (GO:0007566) | 2.26543457 |
| 132 | serine transport (GO:0032329) | 2.26343805 |
| 133 | regulation of endothelial cell apoptotic process (GO:2000351) | 2.25931364 |
| 134 | negative regulation of fibrinolysis (GO:0051918) | 2.25777138 |
| 135 | peptidyl-lysine dimethylation (GO:0018027) | 2.25106087 |
| 136 | lysine catabolic process (GO:0006554) | 2.25103433 |
| 137 | lysine metabolic process (GO:0006553) | 2.25103433 |
| 138 | surfactant homeostasis (GO:0043129) | 2.23513199 |
| 139 | synaptonemal complex organization (GO:0070193) | 2.22608134 |
| 140 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.21036634 |
| 141 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.20835461 |
| 142 | positive regulation of protein deacetylation (GO:0090312) | 2.20731731 |
| 143 | regulation of hexokinase activity (GO:1903299) | 2.20111049 |
| 144 | regulation of glucokinase activity (GO:0033131) | 2.20111049 |
| 145 | cysteine metabolic process (GO:0006534) | 2.18604024 |
| 146 | cellular response to growth hormone stimulus (GO:0071378) | 2.15678144 |
| 147 | mitotic nuclear envelope disassembly (GO:0007077) | 2.14665406 |
| 148 | regulation of chromatin binding (GO:0035561) | 2.14137548 |
| 149 | intestinal epithelial cell development (GO:0060576) | 2.13613413 |
| 150 | * Golgi organization (GO:0007030) | 2.12464882 |
| 151 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 2.09046762 |
| 152 | positive regulation of protein import into nucleus, translocation (GO:0033160) | 2.08904884 |
| 153 | regulation of cholesterol homeostasis (GO:2000188) | 2.08264142 |
| 154 | exocrine pancreas development (GO:0031017) | 2.08204220 |
| 155 | nuclear envelope disassembly (GO:0051081) | 2.07448428 |
| 156 | membrane disassembly (GO:0030397) | 2.07448428 |
| 157 | intestinal cholesterol absorption (GO:0030299) | 2.05944427 |
| 158 | pyrimidine nucleoside monophosphate metabolic process (GO:0009129) | 2.05537960 |
| 159 | sequestering of metal ion (GO:0051238) | 2.03804147 |
| 160 | sulfur amino acid catabolic process (GO:0000098) | 2.03547200 |
| 161 | mitotic sister chromatid cohesion (GO:0007064) | 2.03241938 |
| 162 | macroautophagy (GO:0016236) | 2.02723106 |
| 163 | gene silencing by RNA (GO:0031047) | 2.02330753 |
| 164 | glandular epithelial cell development (GO:0002068) | 2.00971750 |
| 165 | 2-oxoglutarate metabolic process (GO:0006103) | 1.99440032 |
| 166 | pteridine-containing compound biosynthetic process (GO:0042559) | 1.99334087 |
| 167 | xenobiotic catabolic process (GO:0042178) | 1.97735118 |
| 168 | urea cycle (GO:0000050) | 1.96905642 |
| 169 | urea metabolic process (GO:0019627) | 1.96905642 |
| 170 | alpha-linolenic acid metabolic process (GO:0036109) | 1.96755473 |
| 171 | nuclear pore organization (GO:0006999) | 1.95481180 |
| 172 | negative regulation of lipid transport (GO:0032369) | 1.95346678 |
| 173 | male meiosis (GO:0007140) | 1.95176835 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 3.91887083 |
| 2 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 3.76768997 |
| 3 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 3.37439968 |
| 4 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.33157784 |
| 5 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 3.31254893 |
| 6 | E2F7_22180533_ChIP-Seq_HELA_Human | 3.11265758 |
| 7 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.96032609 |
| 8 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.91483012 |
| 9 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 2.76984306 |
| 10 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.57907620 |
| 11 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.48333719 |
| 12 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.42150127 |
| 13 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.39611199 |
| 14 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.26770825 |
| 15 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 2.21966107 |
| 16 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 2.21966107 |
| 17 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.20833256 |
| 18 | MYC_22102868_ChIP-Seq_BL_Human | 2.16315718 |
| 19 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 2.12696960 |
| 20 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.11498989 |
| 21 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.08257703 |
| 22 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.08070950 |
| 23 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 2.06642207 |
| 24 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.97741171 |
| 25 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.96579150 |
| 26 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.93125389 |
| 27 | BRD4_25478319_ChIP-Seq_HGPS_Human | 1.84356320 |
| 28 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.82314442 |
| 29 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.76471000 |
| 30 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.74053869 |
| 31 | GATA1_22025678_ChIP-Seq_K562_Human | 1.72830327 |
| 32 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.70125391 |
| 33 | EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 1.69550335 |
| 34 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.69416189 |
| 35 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.67448024 |
| 36 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.60549639 |
| 37 | CJUN_26792858_Chip-Seq_BT549_Human | 1.59511895 |
| 38 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.59378153 |
| 39 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.57849860 |
| 40 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.56978986 |
| 41 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.56626950 |
| 42 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.55826378 |
| 43 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.55195882 |
| 44 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.54109750 |
| 45 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.52390490 |
| 46 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.51351213 |
| 47 | MYB_26560356_Chip-Seq_TH2_Human | 1.49123819 |
| 48 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.48794550 |
| 49 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.47619271 |
| 50 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.46758173 |
| 51 | MYB_26560356_Chip-Seq_TH1_Human | 1.46650418 |
| 52 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.46640751 |
| 53 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.46223318 |
| 54 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.45744461 |
| 55 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.45206461 |
| 56 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.44222664 |
| 57 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.44037150 |
| 58 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.40482853 |
| 59 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.39398808 |
| 60 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.39043894 |
| 61 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.38145465 |
| 62 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 1.34528769 |
| 63 | * FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.34015125 |
| 64 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.33466437 |
| 65 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.33396179 |
| 66 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.32985816 |
| 67 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.32985816 |
| 68 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.32684564 |
| 69 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 1.30711275 |
| 70 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.29688053 |
| 71 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.29447157 |
| 72 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.28831101 |
| 73 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.28506367 |
| 74 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.27736847 |
| 75 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.27680247 |
| 76 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.26816477 |
| 77 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.25833552 |
| 78 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.24093402 |
| 79 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.24045807 |
| 80 | ATF3_27146783_Chip-Seq_COLON_Human | 1.23580381 |
| 81 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.23093683 |
| 82 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 1.22910543 |
| 83 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.22573825 |
| 84 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.22464323 |
| 85 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 1.22309875 |
| 86 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.22240762 |
| 87 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.21439033 |
| 88 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.21439033 |
| 89 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.21439033 |
| 90 | MAF_26560356_Chip-Seq_TH1_Human | 1.20067692 |
| 91 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.19826119 |
| 92 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.19802792 |
| 93 | UTX_26944678_Chip-Seq_JUKART_Human | 1.19454007 |
| 94 | * ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.19000875 |
| 95 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.18811957 |
| 96 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.18637911 |
| 97 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.18461868 |
| 98 | * TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.18005085 |
| 99 | * TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.18005085 |
| 100 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.17582419 |
| 101 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.17295570 |
| 102 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 1.16062137 |
| 103 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.15153294 |
| 104 | * JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.14200742 |
| 105 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.13507333 |
| 106 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.13206439 |
| 107 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.13010571 |
| 108 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.12788701 |
| 109 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.12194677 |
| 110 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 1.10958254 |
| 111 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.10917437 |
| 112 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 1.10773443 |
| 113 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.10291206 |
| 114 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.09987553 |
| 115 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.09929933 |
| 116 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.09582010 |
| 117 | CHD1_26751641_Chip-Seq_LNCaP_Human | 1.09552452 |
| 118 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.09230608 |
| 119 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.09132541 |
| 120 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.08238156 |
| 121 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.08152270 |
| 122 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.07636514 |
| 123 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.07597115 |
| 124 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.07566097 |
| 125 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 1.05824697 |
| 126 | TP63_23658742_ChIP-Seq_EP156T_Human | 1.05723767 |
| 127 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.05452444 |
| 128 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.05416847 |
| 129 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.04764137 |
| 130 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.04504057 |
| 131 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.04424557 |
| 132 | * STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.04368478 |
| 133 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.04039198 |
| 134 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 1.03986218 |
| 135 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.03823392 |
| 136 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.03471430 |
| 137 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.01789855 |
| 138 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.01380674 |
| 139 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.01176212 |
| 140 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.01133379 |
| 141 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.00946085 |
| 142 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.00801191 |
| 143 | * CREM_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.00608612 |
| 144 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.96950000 |
| 145 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.96791939 |
| 146 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.96735651 |
| 147 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.96723688 |
| 148 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.96663075 |
| 149 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.96510405 |
| 150 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 0.95683564 |
| 151 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.95361925 |
| 152 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.94906234 |
| 153 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.94822752 |
| 154 | KDM5A_27292631_Chip-Seq_BREAST_Human | 0.93498828 |
| 155 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.92830779 |
| 156 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.92142355 |
| 157 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.91501845 |
| 158 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.91228086 |
| 159 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.91205515 |
| 160 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.90569857 |
| 161 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.90079223 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004272_abnormal_basement_membrane | 3.44411141 |
| 2 | MP0002877_abnormal_melanocyte_morpholog | 3.43996562 |
| 3 | MP0003806_abnormal_nucleotide_metabolis | 3.33860924 |
| 4 | MP0005275_abnormal_skin_tensile | 2.55269017 |
| 5 | MP0003941_abnormal_skin_development | 2.54262909 |
| 6 | MP0002139_abnormal_hepatobiliary_system | 2.34887227 |
| 7 | MP0009780_abnormal_chondrocyte_physiolo | 2.32005876 |
| 8 | MP0005365_abnormal_bile_salt | 2.22703319 |
| 9 | MP0003705_abnormal_hypodermis_morpholog | 2.20773507 |
| 10 | MP0010234_abnormal_vibrissa_follicle | 2.16119702 |
| 11 | MP0005257_abnormal_intraocular_pressure | 2.11616371 |
| 12 | MP0003300_gastrointestinal_ulcer | 2.08917262 |
| 13 | MP0004233_abnormal_muscle_weight | 2.05476344 |
| 14 | MP0008260_abnormal_autophagy | 1.90005151 |
| 15 | MP0003252_abnormal_bile_duct | 1.79836003 |
| 16 | MP0003950_abnormal_plasma_membrane | 1.78972208 |
| 17 | MP0010352_gastrointestinal_tract_polyps | 1.78406668 |
| 18 | MP0003091_abnormal_cell_migration | 1.75695252 |
| 19 | MP0005360_urolithiasis | 1.74557578 |
| 20 | MP0002796_impaired_skin_barrier | 1.74122700 |
| 21 | MP0005451_abnormal_body_composition | 1.71593037 |
| 22 | MP0008438_abnormal_cutaneous_collagen | 1.69761807 |
| 23 | MP0004264_abnormal_extraembryonic_tissu | 1.58312293 |
| 24 | MP0006054_spinal_hemorrhage | 1.57131062 |
| 25 | MP0005085_abnormal_gallbladder_physiolo | 1.55799683 |
| 26 | MP0005220_abnormal_exocrine_pancreas | 1.54731412 |
| 27 | MP0003566_abnormal_cell_adhesion | 1.52741212 |
| 28 | MP0001958_emphysema | 1.48236050 |
| 29 | MP0005623_abnormal_meninges_morphology | 1.45063064 |
| 30 | MP0002166_altered_tumor_susceptibility | 1.44528294 |
| 31 | MP0009840_abnormal_foam_cell | 1.43820705 |
| 32 | MP0001666_abnormal_nutrient_absorption | 1.42934368 |
| 33 | MP0010307_abnormal_tumor_latency | 1.41530214 |
| 34 | MP0003279_aneurysm | 1.40627087 |
| 35 | MP0003693_abnormal_embryo_hatching | 1.39950638 |
| 36 | MP0002693_abnormal_pancreas_physiology | 1.39593893 |
| 37 | MP0010678_abnormal_skin_adnexa | 1.39028200 |
| 38 | MP0002138_abnormal_hepatobiliary_system | 1.38564281 |
| 39 | MP0002896_abnormal_bone_mineralization | 1.38289611 |
| 40 | MP0003183_abnormal_peptide_metabolism | 1.35754649 |
| 41 | MP0001944_abnormal_pancreas_morphology | 1.34216943 |
| 42 | MP0005083_abnormal_biliary_tract | 1.32583793 |
| 43 | MP0003221_abnormal_cardiomyocyte_apopto | 1.30029179 |
| 44 | MP0005503_abnormal_tendon_morphology | 1.28857578 |
| 45 | MP0005023_abnormal_wound_healing | 1.28697502 |
| 46 | MP0000767_abnormal_smooth_muscle | 1.25519279 |
| 47 | MP0005501_abnormal_skin_physiology | 1.24658602 |
| 48 | MP0008875_abnormal_xenobiotic_pharmacok | 1.22230976 |
| 49 | MP0009643_abnormal_urine_homeostasis | 1.22015778 |
| 50 | MP0000609_abnormal_liver_physiology | 1.21377603 |
| 51 | MP0004782_abnormal_surfactant_physiolog | 1.20428385 |
| 52 | MP0005076_abnormal_cell_differentiation | 1.19168768 |
| 53 | MP0005408_hypopigmentation | 1.16184076 |
| 54 | MP0002295_abnormal_pulmonary_circulatio | 1.14889973 |
| 55 | MP0010329_abnormal_lipoprotein_level | 1.14707034 |
| 56 | MP0005164_abnormal_response_to | 1.13696392 |
| 57 | MP0001542_abnormal_bone_strength | 1.12866725 |
| 58 | MP0001873_stomach_inflammation | 1.11841084 |
| 59 | MP0005058_abnormal_lysosome_morphology | 1.11540112 |
| 60 | MP0002009_preneoplasia | 1.10243649 |
| 61 | MP0003763_abnormal_thymus_physiology | 1.09896072 |
| 62 | MP0004808_abnormal_hematopoietic_stem | 1.09026054 |
| 63 | MP0000627_abnormal_mammary_gland | 1.09016003 |
| 64 | MP0001243_abnormal_dermal_layer | 1.06809224 |
| 65 | MP0001835_abnormal_antigen_presentation | 1.06350872 |
| 66 | MP0010368_abnormal_lymphatic_system | 1.05673305 |
| 67 | MP0003656_abnormal_erythrocyte_physiolo | 1.04806730 |
| 68 | MP0003436_decreased_susceptibility_to | 1.03093415 |
| 69 | MP0001216_abnormal_epidermal_layer | 1.03063442 |
| 70 | MP0000678_abnormal_parathyroid_gland | 1.02429812 |
| 71 | MP0008007_abnormal_cellular_replicative | 1.01542525 |
| 72 | MP0004947_skin_inflammation | 1.00925596 |
| 73 | MP0002006_tumorigenesis | 1.00051848 |
| 74 | MP0003195_calcinosis | 0.98978893 |
| 75 | MP0003191_abnormal_cellular_cholesterol | 0.98071941 |
| 76 | MP0003448_altered_tumor_morphology | 0.97646437 |
| 77 | MP0001849_ear_inflammation | 0.97269759 |
| 78 | MP0000762_abnormal_tongue_morphology | 0.97152463 |
| 79 | MP0000598_abnormal_liver_morphology | 0.96669224 |
| 80 | MP0005319_abnormal_enzyme/_coenzyme | 0.95624699 |
| 81 | MP0003828_pulmonary_edema | 0.94905099 |
| 82 | MP0000685_abnormal_immune_system | 0.94706860 |
| 83 | MP0001661_extended_life_span | 0.94361993 |
| 84 | MP0000490_abnormal_crypts_of | 0.93708370 |
| 85 | MP0003172_abnormal_lysosome_physiology | 0.93462806 |
| 86 | MP0008877_abnormal_DNA_methylation | 0.93280759 |
| 87 | MP0005621_abnormal_cell_physiology | 0.92281944 |
| 88 | MP0004957_abnormal_blastocyst_morpholog | 0.92275309 |
| 89 | MP0003186_abnormal_redox_activity | 0.92242448 |
| 90 | MP0002933_joint_inflammation | 0.89459181 |
| 91 | MP0002060_abnormal_skin_morphology | 0.88379030 |
| 92 | MP0002086_abnormal_extraembryonic_tissu | 0.88120430 |
| 93 | MP0003453_abnormal_keratinocyte_physiol | 0.87566601 |
| 94 | MP0001915_intracranial_hemorrhage | 0.87078852 |
| 95 | MP0008961_abnormal_basal_metabolism | 0.86718280 |
| 96 | MP0001800_abnormal_humoral_immune | 0.86162307 |
| 97 | MP0005375_adipose_tissue_phenotype | 0.86021305 |
| 98 | MP0002269_muscular_atrophy | 0.85623033 |
| 99 | MP0002405_respiratory_system_inflammati | 0.85313140 |
| 100 | MP0005397_hematopoietic_system_phenotyp | 0.85112554 |
| 101 | MP0001545_abnormal_hematopoietic_system | 0.85112554 |
| 102 | MP0003795_abnormal_bone_structure | 0.84627495 |
| 103 | MP0000858_altered_metastatic_potential | 0.83927466 |
| 104 | MP0010155_abnormal_intestine_physiology | 0.83781859 |
| 105 | MP0002254_reproductive_system_inflammat | 0.83688001 |
| 106 | MP0000465_gastrointestinal_hemorrhage | 0.83488102 |
| 107 | MP0003077_abnormal_cell_cycle | 0.83273461 |
| 108 | MP0001881_abnormal_mammary_gland | 0.83248587 |
| 109 | MP0001879_abnormal_lymphatic_vessel | 0.83162979 |
| 110 | MP0005310_abnormal_salivary_gland | 0.83108785 |
| 111 | MP0001845_abnormal_inflammatory_respons | 0.83065637 |
| 112 | MP0001730_embryonic_growth_arrest | 0.82446187 |
| 113 | MP0008004_abnormal_stomach_pH | 0.82326683 |
| 114 | MP0002078_abnormal_glucose_homeostasis | 0.81818597 |
| 115 | MP0000013_abnormal_adipose_tissue | 0.80303827 |
| 116 | MP0000377_abnormal_hair_follicle | 0.79805168 |
| 117 | MP0002837_dystrophic_cardiac_calcinosis | 0.79626394 |
| 118 | MP0003868_abnormal_feces_composition | 0.79501550 |
| 119 | MP0003984_embryonic_growth_retardation | 0.79383600 |
| 120 | MP0000371_diluted_coat_color | 0.78830920 |
| 121 | MP0005464_abnormal_platelet_physiology | 0.78311515 |
| 122 | MP0002019_abnormal_tumor_incidence | 0.76924856 |
| 123 | MP0001764_abnormal_homeostasis | 0.76836962 |
| 124 | MP0001790_abnormal_immune_system | 0.76555109 |
| 125 | MP0005387_immune_system_phenotype | 0.76555109 |
| 126 | MP0001756_abnormal_urination | 0.76240908 |
| 127 | MP0002088_abnormal_embryonic_growth/wei | 0.76083595 |
| 128 | MP0002452_abnormal_antigen_presenting | 0.75840604 |
| 129 | MP0001672_abnormal_embryogenesis/_devel | 0.75138321 |
| 130 | MP0005380_embryogenesis_phenotype | 0.75138321 |
| 131 | MP0000689_abnormal_spleen_morphology | 0.74255963 |
| 132 | MP0010386_abnormal_urinary_bladder | 0.74073965 |
| 133 | MP0002118_abnormal_lipid_homeostasis | 0.72062871 |
| 134 | MP0002398_abnormal_bone_marrow | 0.71969752 |
| 135 | MP0001533_abnormal_skeleton_physiology | 0.71835226 |
| 136 | MP0005384_cellular_phenotype | 0.71784259 |
| 137 | MP0002419_abnormal_innate_immunity | 0.71619490 |
| 138 | MP0002396_abnormal_hematopoietic_system | 0.71239202 |
| 139 | MP0000733_abnormal_muscle_development | 0.71052752 |
| 140 | MP0009384_cardiac_valve_regurgitation | 0.71048693 |
| 141 | MP0001727_abnormal_embryo_implantation | 0.69992823 |
| 142 | MP0000751_myopathy | 0.69438598 |
| 143 | MP0002928_abnormal_bile_duct | 0.69232149 |
| 144 | MP0003943_abnormal_hepatobiliary_system | 0.68454980 |
| 145 | MP0001614_abnormal_blood_vessel | 0.68174847 |
| 146 | MP0005165_increased_susceptibility_to | 0.67976124 |
| 147 | MP0008469_abnormal_protein_level | 0.67776052 |
| 148 | MP0000003_abnormal_adipose_tissue | 0.67726327 |
| 149 | MP0005508_abnormal_skeleton_morphology | 0.67358910 |
| 150 | MP0002998_abnormal_bone_remodeling | 0.67138291 |
| 151 | MP0010771_integument_phenotype | 0.66309887 |
| 152 | MP0009697_abnormal_copulation | 0.66251198 |
| 153 | MP0000462_abnormal_digestive_system | 0.65305765 |
| 154 | MP0006138_congestive_heart_failure | 0.65279170 |
| 155 | MP0002722_abnormal_immune_system | 0.65253236 |
| 156 | MP0004185_abnormal_adipocyte_glucose | 0.65149904 |
| 157 | MP0005197_abnormal_uvea_morphology | 0.62271494 |
| 158 | MP0000604_amyloidosis | 0.62061030 |
| 159 | MP0002098_abnormal_vibrissa_morphology | 0.61725692 |
| 160 | MP0001299_abnormal_eye_distance/ | 0.60588982 |
| 161 | MP0000467_abnormal_esophagus_morphology | 0.60486006 |
| 162 | MP0005666_abnormal_adipose_tissue | 0.58405140 |
| 163 | MP0004858_abnormal_nervous_system | 0.57990445 |
| 164 | MP0005409_darkened_coat_color | 0.57870599 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Premature rupture of membranes (HP:0001788) | 5.17526317 |
| 2 | Hypoglycemic coma (HP:0001325) | 3.75037890 |
| 3 | Vascular tortuosity (HP:0004948) | 3.58189431 |
| 4 | Arterial tortuosity (HP:0005116) | 3.57231343 |
| 5 | Atrophic scars (HP:0001075) | 3.47166386 |
| 6 | Vertebral compression fractures (HP:0002953) | 3.40342197 |
| 7 | Aortic dissection (HP:0002647) | 3.19199057 |
| 8 | Abnormality of the intrinsic pathway (HP:0010989) | 2.90692974 |
| 9 | Hypoglycemic seizures (HP:0002173) | 2.86901807 |
| 10 | Right ventricular cardiomyopathy (HP:0011663) | 2.85996846 |
| 11 | Abnormal foot bone ossification (HP:0010675) | 2.84949660 |
| 12 | Osteolytic defects of the hand bones (HP:0009699) | 2.82234193 |
| 13 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.82234193 |
| 14 | IgM deficiency (HP:0002850) | 2.81907062 |
| 15 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.80078061 |
| 16 | Hyperglycemia (HP:0003074) | 2.79800406 |
| 17 | Beaking of vertebral bodies (HP:0004568) | 2.79428926 |
| 18 | Abnormality of dentin (HP:0010299) | 2.78052846 |
| 19 | Mitral stenosis (HP:0001718) | 2.76626025 |
| 20 | Tetraparesis (HP:0002273) | 2.74382073 |
| 21 | Wormian bones (HP:0002645) | 2.73190530 |
| 22 | Cervical subluxation (HP:0003308) | 2.72244256 |
| 23 | Back pain (HP:0003418) | 2.61466881 |
| 24 | Thrombocytosis (HP:0001894) | 2.56907450 |
| 25 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.49776221 |
| 26 | Intrahepatic cholestasis (HP:0001406) | 2.49043569 |
| 27 | Myocardial infarction (HP:0001658) | 2.48716154 |
| 28 | Asymmetry of the thorax (HP:0001555) | 2.47272529 |
| 29 | Insulin-resistant diabetes mellitus (HP:0000831) | 2.44141652 |
| 30 | Abnormality of the common coagulation pathway (HP:0010990) | 2.42748845 |
| 31 | Ulnar deviation of the wrist (HP:0003049) | 2.40449195 |
| 32 | Fragile skin (HP:0001030) | 2.39406412 |
| 33 | Degeneration of anterior horn cells (HP:0002398) | 2.38656818 |
| 34 | Abnormality of the anterior horn cell (HP:0006802) | 2.38656818 |
| 35 | Flat acetabular roof (HP:0003180) | 2.38176805 |
| 36 | Abnormality of endocrine pancreas physiology (HP:0012093) | 2.38151778 |
| 37 | Abnormality of the pancreatic islet cells (HP:0006476) | 2.38151778 |
| 38 | Abnormal pancreas size (HP:0012094) | 2.37792680 |
| 39 | Ketoacidosis (HP:0001993) | 2.37381530 |
| 40 | Thoracolumbar scoliosis (HP:0002944) | 2.34833392 |
| 41 | Renal cortical cysts (HP:0000803) | 2.34295766 |
| 42 | Short nail (HP:0001799) | 2.32943986 |
| 43 | Spondylolisthesis (HP:0003302) | 2.30333945 |
| 44 | Cardiovascular calcification (HP:0011915) | 2.29483222 |
| 45 | Abnormal tarsal ossification (HP:0008369) | 2.28120859 |
| 46 | Ankle contracture (HP:0006466) | 2.27542729 |
| 47 | Mucopolysacchariduria (HP:0008155) | 2.26966097 |
| 48 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.26966097 |
| 49 | Abnormal delivery (HP:0001787) | 2.25441926 |
| 50 | Blue sclerae (HP:0000592) | 2.22587374 |
| 51 | Follicular hyperkeratosis (HP:0007502) | 2.21769691 |
| 52 | Metaphyseal cupping (HP:0003021) | 2.21512323 |
| 53 | Hypoplastic ischia (HP:0003175) | 2.21317415 |
| 54 | Vacuolated lymphocytes (HP:0001922) | 2.21099145 |
| 55 | Generalized aminoaciduria (HP:0002909) | 2.18198204 |
| 56 | Dilatation of the ascending aorta (HP:0005111) | 2.15771610 |
| 57 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.15735361 |
| 58 | Abnormality of the fingertips (HP:0001211) | 2.12746295 |
| 59 | Upper limb amyotrophy (HP:0009129) | 2.12167343 |
| 60 | Distal upper limb amyotrophy (HP:0007149) | 2.12167343 |
| 61 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.10713538 |
| 62 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.10713538 |
| 63 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.10713538 |
| 64 | Soft skin (HP:0000977) | 2.09571776 |
| 65 | Deep venous thrombosis (HP:0002625) | 2.09369775 |
| 66 | Severe short stature (HP:0003510) | 2.08056405 |
| 67 | Abnormality of carpal bone ossification (HP:0006257) | 2.04960121 |
| 68 | Ketosis (HP:0001946) | 2.04288032 |
| 69 | * Papillary thyroid carcinoma (HP:0002895) | 2.03951993 |
| 70 | Spinal rigidity (HP:0003306) | 2.03303644 |
| 71 | Mitral valve prolapse (HP:0001634) | 2.02682295 |
| 72 | Insulin resistance (HP:0000855) | 2.01462429 |
| 73 | Elbow flexion contracture (HP:0002987) | 2.01283487 |
| 74 | Advanced eruption of teeth (HP:0006288) | 2.00935309 |
| 75 | Insidious onset (HP:0003587) | 2.00798007 |
| 76 | Termporal pattern (HP:0011008) | 2.00798007 |
| 77 | Symptomatic seizures (HP:0011145) | 1.99272721 |
| 78 | Microglossia (HP:0000171) | 1.98812300 |
| 79 | Abnormality of purine metabolism (HP:0004352) | 1.98630395 |
| 80 | Natal tooth (HP:0000695) | 1.98420116 |
| 81 | Long toe (HP:0010511) | 1.98363600 |
| 82 | Conjugated hyperbilirubinemia (HP:0002908) | 1.97993440 |
| 83 | Joint laxity (HP:0001388) | 1.97371674 |
| 84 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.95743927 |
| 85 | Autoamputation (HP:0001218) | 1.94747874 |
| 86 | Vascular calcification (HP:0004934) | 1.93329111 |
| 87 | Breech presentation (HP:0001623) | 1.93023211 |
| 88 | Prominent metopic ridge (HP:0005487) | 1.92717524 |
| 89 | Cerebral aneurysm (HP:0004944) | 1.92426451 |
| 90 | Epiphyseal dysplasia (HP:0002656) | 1.92167856 |
| 91 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.91925595 |
| 92 | Hyperextensible skin (HP:0000974) | 1.91792770 |
| 93 | Aortic aneurysm (HP:0004942) | 1.91778205 |
| 94 | Abnormality of T cell physiology (HP:0011840) | 1.90578869 |
| 95 | Micronodular cirrhosis (HP:0001413) | 1.90164046 |
| 96 | Unilateral renal agenesis (HP:0000122) | 1.87808063 |
| 97 | Malnutrition (HP:0004395) | 1.87356964 |
| 98 | Abnormality of the ischium (HP:0003174) | 1.87123929 |
| 99 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.86584873 |
| 100 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.86584873 |
| 101 | Abnormality of glycolipid metabolism (HP:0010969) | 1.86584873 |
| 102 | Late onset (HP:0003584) | 1.86057765 |
| 103 | Protuberant abdomen (HP:0001538) | 1.85612784 |
| 104 | Bladder diverticulum (HP:0000015) | 1.85588308 |
| 105 | Cupped ribs (HP:0000887) | 1.85332464 |
| 106 | Asymmetric septal hypertrophy (HP:0001670) | 1.84057161 |
| 107 | Polycythemia (HP:0001901) | 1.83752584 |
| 108 | Global brain atrophy (HP:0002283) | 1.83142959 |
| 109 | Ankyloglossia (HP:0010296) | 1.82779962 |
| 110 | Esophageal varix (HP:0002040) | 1.82335714 |
| 111 | Gout (HP:0001997) | 1.81809347 |
| 112 | Dysostosis multiplex (HP:0000943) | 1.81744105 |
| 113 | Epidermoid cyst (HP:0200040) | 1.80940541 |
| 114 | Neonatal short-limb short stature (HP:0008921) | 1.80853835 |
| 115 | Generalized amyotrophy (HP:0003700) | 1.79815285 |
| 116 | Colitis (HP:0002583) | 1.79802217 |
| 117 | Pancreatic islet-cell hyperplasia (HP:0004510) | 1.78170443 |
| 118 | Xanthomatosis (HP:0000991) | 1.78104051 |
| 119 | Abdominal distention (HP:0003270) | 1.77711217 |
| 120 | Increased mean platelet volume (HP:0011877) | 1.77200184 |
| 121 | Curly hair (HP:0002212) | 1.76483831 |
| 122 | Nasal polyposis (HP:0100582) | 1.74962314 |
| 123 | Abnormality of the nasal mucosa (HP:0000433) | 1.74292038 |
| 124 | Peritonitis (HP:0002586) | 1.73567963 |
| 125 | Facial diplegia (HP:0001349) | 1.72721965 |
| 126 | Hypobetalipoproteinemia (HP:0003563) | 1.72714041 |
| 127 | Hand muscle atrophy (HP:0009130) | 1.72248488 |
| 128 | Pterygium (HP:0001059) | 1.70888462 |
| 129 | Flattened epiphyses (HP:0003071) | 1.70796125 |
| 130 | Abnormality of the thoracic spine (HP:0100711) | 1.70764783 |
| 131 | Abnormality of small intestinal villus morphology (HP:0011472) | 1.70614832 |
| 132 | Villous atrophy (HP:0011473) | 1.70614832 |
| 133 | Protrusio acetabuli (HP:0003179) | 1.70132754 |
| 134 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.69587689 |
| 135 | Ovoid vertebral bodies (HP:0003300) | 1.68870673 |
| 136 | Abnormal platelet volume (HP:0011876) | 1.67911735 |
| 137 | Thoracic kyphosis (HP:0002942) | 1.67550583 |
| 138 | Fatigue (HP:0012378) | 1.66815124 |
| 139 | Irregular epiphyses (HP:0010582) | 1.66790273 |
| 140 | Male infertility (HP:0003251) | 1.66675050 |
| 141 | Recurrent bronchitis (HP:0002837) | 1.66124499 |
| 142 | Prolonged partial thromboplastin time (HP:0003645) | 1.65251831 |
| 143 | Flat capital femoral epiphysis (HP:0003370) | 1.65142612 |
| 144 | Large for gestational age (HP:0001520) | 1.64583371 |
| 145 | Fat malabsorption (HP:0002630) | 1.64228225 |
| 146 | Spinal cord compression (HP:0002176) | 1.63622629 |
| 147 | Hypolipoproteinemia (HP:0010981) | 1.63350486 |
| 148 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.63015157 |
| 149 | Gastrointestinal inflammation (HP:0004386) | 1.62929675 |
| 150 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.62730693 |
| 151 | Aneurysm (HP:0002617) | 1.62351291 |
| 152 | Platyspondyly (HP:0000926) | 1.61753012 |
| 153 | Coxa valga (HP:0002673) | 1.61671608 |
| 154 | Hypoalphalipoproteinemia (HP:0003233) | 1.61287737 |
| 155 | Glucose intolerance (HP:0000833) | 1.61277105 |
| 156 | Abnormality of oral frenula (HP:0000190) | 1.61147526 |
| 157 | Limb hypertonia (HP:0002509) | 1.61130597 |
| 158 | Abnormal gallbladder physiology (HP:0012438) | 1.61072494 |
| 159 | Cholecystitis (HP:0001082) | 1.61072494 |
| 160 | Reduced subcutaneous adipose tissue (HP:0003758) | 1.61010818 |
| 161 | Coarse hair (HP:0002208) | 1.60842299 |
| 162 | Upper limb muscle weakness (HP:0003484) | 1.60841698 |
| 163 | Abnormality of the acetabulum (HP:0003170) | 1.60552671 |
| 164 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.60511196 |
| 165 | Abnormality of the Achilles tendon (HP:0005109) | 1.59067606 |
| 166 | Thin bony cortex (HP:0002753) | 1.58788261 |
| 167 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.58144329 |
| 168 | Aplasia/Hypoplasia of the frontal sinuses (HP:0009119) | 1.57526678 |
| 169 | Alopecia of scalp (HP:0002293) | 1.57466167 |
| 170 | Genu recurvatum (HP:0002816) | 1.55511718 |
| 171 | Testicular neoplasm (HP:0010788) | 1.55498823 |
| 172 | Limb-girdle muscle weakness (HP:0003325) | 1.55005215 |
| 173 | Abnormal ossification of hand bones (HP:0005921) | 1.54902948 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EEF2K | 2.99492750 |
| 2 | EIF2AK1 | 2.98531885 |
| 3 | PKN2 | 2.88769583 |
| 4 | TAOK3 | 2.82572915 |
| 5 | FLT3 | 2.69513451 |
| 6 | TRIB3 | 2.62134428 |
| 7 | PASK | 2.58502433 |
| 8 | MET | 2.54228908 |
| 9 | ERN1 | 2.50343130 |
| 10 | MAP3K12 | 2.47755268 |
| 11 | MST1R | 2.33764953 |
| 12 | MYLK | 2.11492333 |
| 13 | MST4 | 2.11051678 |
| 14 | MAPKAPK3 | 2.06576975 |
| 15 | LATS2 | 2.04164112 |
| 16 | STK10 | 2.01161000 |
| 17 | TIE1 | 1.99675152 |
| 18 | FRK | 1.96376743 |
| 19 | JAK3 | 1.93145177 |
| 20 | RPS6KA4 | 1.81284898 |
| 21 | RIPK1 | 1.76857589 |
| 22 | DDR2 | 1.67507299 |
| 23 | FER | 1.63108838 |
| 24 | MAP3K3 | 1.61310332 |
| 25 | PRKD3 | 1.60584641 |
| 26 | IRAK3 | 1.56915601 |
| 27 | ZAP70 | 1.54362221 |
| 28 | MAP2K3 | 1.51979435 |
| 29 | MAP4K1 | 1.50726794 |
| 30 | TTN | 1.49096267 |
| 31 | PBK | 1.48867046 |
| 32 | SIK1 | 1.45611688 |
| 33 | LATS1 | 1.43514245 |
| 34 | STK24 | 1.39989759 |
| 35 | NEK2 | 1.36532458 |
| 36 | CDC7 | 1.35178668 |
| 37 | BCKDK | 1.34772328 |
| 38 | MAP3K13 | 1.33497830 |
| 39 | RPS6KB2 | 1.32648813 |
| 40 | MOS | 1.31181157 |
| 41 | AKT3 | 1.30496292 |
| 42 | SCYL2 | 1.29953991 |
| 43 | FGFR4 | 1.27463308 |
| 44 | BRSK2 | 1.27201467 |
| 45 | TYK2 | 1.25880709 |
| 46 | PDK4 | 1.25848591 |
| 47 | PDK3 | 1.25848591 |
| 48 | NEK9 | 1.24364535 |
| 49 | KSR1 | 1.21979649 |
| 50 | HIPK2 | 1.21831631 |
| 51 | PTK6 | 1.19414425 |
| 52 | TGFBR2 | 1.19141117 |
| 53 | DYRK3 | 1.17782849 |
| 54 | NEK1 | 1.17114956 |
| 55 | TESK1 | 1.13786740 |
| 56 | ERBB3 | 1.13469709 |
| 57 | LIMK1 | 1.11002046 |
| 58 | MAP3K8 | 1.06497451 |
| 59 | BRD4 | 1.05591948 |
| 60 | STK3 | 1.05091428 |
| 61 | EIF2AK3 | 1.03741259 |
| 62 | ACVR1B | 1.02659506 |
| 63 | ERBB4 | 1.02246007 |
| 64 | NEK6 | 1.01981230 |
| 65 | MAP3K10 | 1.01368409 |
| 66 | MARK3 | 0.99424260 |
| 67 | ICK | 0.94895309 |
| 68 | PIK3CG | 0.93756785 |
| 69 | NLK | 0.93145210 |
| 70 | TBK1 | 0.92696725 |
| 71 | LRRK2 | 0.92102634 |
| 72 | STK38L | 0.90197925 |
| 73 | CHUK | 0.88788720 |
| 74 | KSR2 | 0.88644942 |
| 75 | FGR | 0.87117163 |
| 76 | BCR | 0.86454827 |
| 77 | JAK2 | 0.86271504 |
| 78 | STK38 | 0.85895135 |
| 79 | EPHA3 | 0.84582923 |
| 80 | PDK2 | 0.83615905 |
| 81 | NTRK1 | 0.82852748 |
| 82 | JAK1 | 0.81753233 |
| 83 | PAK2 | 0.80071895 |
| 84 | PAK4 | 0.78125519 |
| 85 | PDGFRA | 0.77789418 |
| 86 | LMTK2 | 0.75946683 |
| 87 | ILK | 0.75779473 |
| 88 | PDGFRB | 0.73864666 |
| 89 | BTK | 0.72722172 |
| 90 | TRPM7 | 0.71990472 |
| 91 | ITK | 0.71689847 |
| 92 | EPHA2 | 0.71245831 |
| 93 | ROCK2 | 0.70672495 |
| 94 | MTOR | 0.70616594 |
| 95 | MAPK11 | 0.70462328 |
| 96 | FGFR3 | 0.69503851 |
| 97 | PRPF4B | 0.69417388 |
| 98 | CAMK1D | 0.68570768 |
| 99 | YES1 | 0.68556604 |
| 100 | MAP3K14 | 0.66940411 |
| 101 | ARAF | 0.66704480 |
| 102 | CDK9 | 0.66313035 |
| 103 | TTK | 0.66248303 |
| 104 | BMX | 0.60756128 |
| 105 | PRKD2 | 0.60627024 |
| 106 | SGK3 | 0.60460960 |
| 107 | TEC | 0.59038044 |
| 108 | EPHB1 | 0.58232303 |
| 109 | CDK12 | 0.57550139 |
| 110 | FGFR1 | 0.57001823 |
| 111 | PIM1 | 0.56081202 |
| 112 | IKBKE | 0.55815224 |
| 113 | MAPK15 | 0.55443865 |
| 114 | EPHB2 | 0.55262440 |
| 115 | RET | 0.55005175 |
| 116 | MAP2K6 | 0.54883101 |
| 117 | PTK2 | 0.53630870 |
| 118 | CSF1R | 0.52993082 |
| 119 | CDC42BPA | 0.52642894 |
| 120 | AKT2 | 0.52205698 |
| 121 | TGFBR1 | 0.51924699 |
| 122 | MAP3K2 | 0.51781252 |
| 123 | INSRR | 0.51573058 |
| 124 | MAP3K6 | 0.50557492 |
| 125 | KIT | 0.50127367 |
| 126 | DYRK1B | 0.48990746 |
| 127 | CDK7 | 0.48049977 |
| 128 | MAP3K9 | 0.47886037 |
| 129 | STK4 | 0.47376204 |
| 130 | IRAK4 | 0.45890156 |
| 131 | MUSK | 0.44976423 |
| 132 | RAF1 | 0.44413443 |
| 133 | MELK | 0.44323441 |
| 134 | BRAF | 0.43962493 |
| 135 | SIK3 | 0.41669070 |
| 136 | PRKG2 | 0.41542231 |
| 137 | CDK6 | 0.40798319 |
| 138 | MAP3K5 | 0.40109282 |
| 139 | AURKB | 0.39028675 |
| 140 | PDK1 | 0.38920658 |
| 141 | CDK4 | 0.38301317 |
| 142 | CAMK1G | 0.37749942 |
| 143 | MAP2K1 | 0.37730282 |
| 144 | TAOK2 | 0.35331112 |
| 145 | ROCK1 | 0.35250583 |
| 146 | DMPK | 0.33945649 |
| 147 | TSSK6 | 0.33917523 |
| 148 | PIK3CA | 0.33518342 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 4.00995060 |
| 2 | Protein export_Homo sapiens_hsa03060 | 2.53356056 |
| 3 | Selenocompound metabolism_Homo sapiens_hsa00450 | 2.51792155 |
| 4 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 2.28388174 |
| 5 | Adherens junction_Homo sapiens_hsa04520 | 1.81953012 |
| 6 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.81140418 |
| 7 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.74981022 |
| 8 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.73509482 |
| 9 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.67423643 |
| 10 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.65814071 |
| 11 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.65269045 |
| 12 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.59093694 |
| 13 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.52307867 |
| 14 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.47594951 |
| 15 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.46203915 |
| 16 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.45702052 |
| 17 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.40539857 |
| 18 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.38168033 |
| 19 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 1.36938047 |
| 20 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.36922779 |
| 21 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.30970875 |
| 22 | Insulin resistance_Homo sapiens_hsa04931 | 1.27174955 |
| 23 | Galactose metabolism_Homo sapiens_hsa00052 | 1.26508260 |
| 24 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.25377792 |
| 25 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.23037408 |
| 26 | Legionellosis_Homo sapiens_hsa05134 | 1.21387491 |
| 27 | Other glycan degradation_Homo sapiens_hsa00511 | 1.19750252 |
| 28 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.18649132 |
| 29 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.18504229 |
| 30 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.16622833 |
| 31 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.15592070 |
| 32 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.14794035 |
| 33 | Circadian rhythm_Homo sapiens_hsa04710 | 1.14705481 |
| 34 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.14304134 |
| 35 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.13597478 |
| 36 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.13501113 |
| 37 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.10107143 |
| 38 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.07766716 |
| 39 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.07542729 |
| 40 | Cell cycle_Homo sapiens_hsa04110 | 1.07511965 |
| 41 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.04518402 |
| 42 | Bladder cancer_Homo sapiens_hsa05219 | 1.03686431 |
| 43 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.02850017 |
| 44 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.01291275 |
| 45 | Endometrial cancer_Homo sapiens_hsa05213 | 1.00526645 |
| 46 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.99679520 |
| 47 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.99130281 |
| 48 | Shigellosis_Homo sapiens_hsa05131 | 0.98116035 |
| 49 | Prion diseases_Homo sapiens_hsa05020 | 0.97253467 |
| 50 | Lysine degradation_Homo sapiens_hsa00310 | 0.93887078 |
| 51 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.93500396 |
| 52 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.93245067 |
| 53 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.93168917 |
| 54 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.93059151 |
| 55 | ABC transporters_Homo sapiens_hsa02010 | 0.91771013 |
| 56 | Peroxisome_Homo sapiens_hsa04146 | 0.87584294 |
| 57 | Thyroid cancer_Homo sapiens_hsa05216 | 0.84797328 |
| 58 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.83520825 |
| 59 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.83025145 |
| 60 | Tight junction_Homo sapiens_hsa04530 | 0.82583557 |
| 61 | Leishmaniasis_Homo sapiens_hsa05140 | 0.82242321 |
| 62 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.81972143 |
| 63 | Endocytosis_Homo sapiens_hsa04144 | 0.81925732 |
| 64 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.79967839 |
| 65 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.79718467 |
| 66 | Histidine metabolism_Homo sapiens_hsa00340 | 0.79608265 |
| 67 | RNA degradation_Homo sapiens_hsa03018 | 0.79292381 |
| 68 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.79148760 |
| 69 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.78229664 |
| 70 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.78123725 |
| 71 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.76993644 |
| 72 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.76613292 |
| 73 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.76552546 |
| 74 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.76528793 |
| 75 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.76383614 |
| 76 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.74530612 |
| 77 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.74027726 |
| 78 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.73648283 |
| 79 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.72448892 |
| 80 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.72172169 |
| 81 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.71935444 |
| 82 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.71583729 |
| 83 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.71111504 |
| 84 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.70139748 |
| 85 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.69789518 |
| 86 | Lysosome_Homo sapiens_hsa04142 | 0.69155880 |
| 87 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.68051393 |
| 88 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.67957417 |
| 89 | Hepatitis C_Homo sapiens_hsa05160 | 0.67955573 |
| 90 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.67435357 |
| 91 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.66845123 |
| 92 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.66820586 |
| 93 | Salmonella infection_Homo sapiens_hsa05132 | 0.66268520 |
| 94 | Apoptosis_Homo sapiens_hsa04210 | 0.65636241 |
| 95 | Influenza A_Homo sapiens_hsa05164 | 0.65145874 |
| 96 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.64273716 |
| 97 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.62556230 |
| 98 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.61707891 |
| 99 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.61565492 |
| 100 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.61267879 |
| 101 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.60882832 |
| 102 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.60794502 |
| 103 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.59892186 |
| 104 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.59524498 |
| 105 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.59472300 |
| 106 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.59366925 |
| 107 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.59303066 |
| 108 | Carbon metabolism_Homo sapiens_hsa01200 | 0.59240611 |
| 109 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.59031892 |
| 110 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.58880398 |
| 111 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.58362943 |
| 112 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.58055697 |
| 113 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.57904683 |
| 114 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.57551480 |
| 115 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.56568439 |
| 116 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.56355998 |
| 117 | RNA transport_Homo sapiens_hsa03013 | 0.55968991 |
| 118 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.55709871 |
| 119 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.55455645 |
| 120 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.55216311 |
| 121 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.55180225 |
| 122 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.54416885 |
| 123 | Mineral absorption_Homo sapiens_hsa04978 | 0.53966916 |
| 124 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.53604322 |
| 125 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.53598980 |
| 126 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.53055199 |
| 127 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.52884257 |
| 128 | Measles_Homo sapiens_hsa05162 | 0.52710974 |
| 129 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.51158490 |
| 130 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.50423989 |
| 131 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.50213178 |
| 132 | HTLV-I infection_Homo sapiens_hsa05166 | 0.50141430 |
| 133 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.49928179 |
| 134 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.48916770 |
| 135 | Prostate cancer_Homo sapiens_hsa05215 | 0.48667285 |
| 136 | Glioma_Homo sapiens_hsa05214 | 0.48337969 |
| 137 | Phagosome_Homo sapiens_hsa04145 | 0.46839561 |
| 138 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.46701477 |
| 139 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.45712527 |
| 140 | Focal adhesion_Homo sapiens_hsa04510 | 0.45653120 |
| 141 | Hepatitis B_Homo sapiens_hsa05161 | 0.45630552 |
| 142 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.45480972 |
| 143 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.45004900 |
| 144 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.43523144 |
| 145 | Amoebiasis_Homo sapiens_hsa05146 | 0.43292577 |
| 146 | Pathways in cancer_Homo sapiens_hsa05200 | 0.42329846 |

